Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CorMedix Inc (NYSE MKT LLC:CRMD)

2.72
Delayed Data
As of Sep 26
 -0.04 / -1.45%
Today’s Change
1.15
Today|||52-Week Range
4.54
+33.99%
Year-to-Date
No recent news for CorMedix Inc.

Today’s Trading

Previous close2.76
Today’s open2.73
Day’s range2.57 - 2.78
Volume583,531
Average volume (3 months)419,345
Market cap$105.8M
Dividend yield--
Data as of 4:01pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)+39.58%
Earnings growth (this year)+2.30%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+11.02%
P/E ratioNM
Price/Sales302.80
Price/Book2.92

Competitors

 Today’s
change
Today’s
% change
AKTXAkari Therapeutics P...+0.03+0.33%
ONSOncobiologics Inc-0.05-1.11%
PSDVpSivida Corp-0.05-1.55%
FATEFate Therapeutics In...-0.03-0.87%
Data as of 3:59pm ET, 09/26/2016

Financials

Next reporting dateNovember 10, 2016
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$210.1K
Annual profit (last year)-$18.2M
Net profit margin-8,655.37%

Profile

Sector
Health Technology
Industry
Medical Specialties
CEO, Director &
Head-Investor Relations
Randy D. Milby
Chief Financial Officer
James R. Altland
Corporate headquarters
Bridgewater, New Jersey

Forecasts

Search for Jobs